Related Experiment Video
Updated: Mar 10, 2026
Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
Published on: August 17, 2016
Optical Properties of Europium Tetracycline Complexes in the Presence of High-Density Lipoproteins (HDL) Subfractions
Letícia Bonfante Sicchieri1, Andrea Moreira Monteiro2, Antônio Martins Figueiredo Neto2
11 Centro de Lasers e Aplicações, IPEN/CNEN, São Paulo, SP, Brazil.
Insights
Standard lipid tests miss lipoprotein abnormalities linked to heart disease. This study shows europium tetracycline can distinguish between high-density lipoprotein (HDL) subspecies, offering a new way to assess cardiovascular risk.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Analytical Chemistry
Background:
- Standard lipid profiles (triglycerides, total cholesterol, LDL, HDL) are insufficient for identifying lipoprotein abnormalities contributing to cardiovascular heart disease (CHD).
- Cardiovascular heart disease (CHD) risk is more strongly linked to high-density lipoprotein (HDL) subspecies than total HDL cholesterol levels.
- HDL particles exist in subfractions (HDL2b, HDL2a, HDL3), with low HDL2 levels specifically associated with atherosclerosis.
Purpose of the Study:
- To investigate the optical spectroscopic properties of a europium tetracycline (EuTc) complex when interacting with different HDL subspecies.
- To determine if EuTc can differentiate between HDL subspecies relevant to cardiovascular risk.
Main Methods:
- Studied the optical spectroscopic properties of europium tetracycline (EuTc) complex.
- Analyzed the influence of varying HDL subspecies (HDL2b, HDL2a, HDL3) sizes and concentrations on EuTc spectroscopic properties.
- Measured Eu3+ emission intensity and lifetime in the presence of different HDL subspecies.
Main Results:
- The spectroscopic properties of europium in the EuTc complex were significantly influenced by the sizes and concentrations of HDL subclasses.
- Eu3+ emission intensity and lifetime demonstrated the ability to discriminate between HDL3 and HDL2b subfractions.
- This suggests a method for differentiating key HDL subspecies.
Conclusions:
- Europium tetracycline's spectroscopic properties are sensitive to HDL subspecies composition.
- Eu3+ emission intensity and lifetime can serve as biomarkers to distinguish between HDL3 and HDL2b, potentially aiding in cardiovascular risk assessment.
- This spectroscopic approach offers a novel method for analyzing lipoprotein abnormalities beyond standard lipid measurements.
Abstract:
Standard lipoprotein measurements of triglycerides, total cholesterol, low-density lipoproteins (LDL), and high-density lipoproteins (HDL) fail to identify many lipoprotein abnormalities that contribute to cardiovascular heart diseases (CHD). Studies suggested that the presence of CHD is more strongly associated with the HDL subspecies than with total HDL cholesterol levels. The HDL particles can be collected in at least three subfractions, the HDL2b, HDL2a, and HDL3. More specifically, atherosclerosis is associated with low levels of HDL2. In this work, the optical spectroscopic properties of europium tetracycline (EuTc) complex in the presence of different HDL subspecies was studied. The results show that the europium spectroscopic properties in the EuTc complex are influenced by sizes and concentrations of subclasses. Eu3+ emission intensity and lifetime can discriminate the subfractions HDL3 and HDL2b.
